PMC:7546716 / 827-1053 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T15","span":{"begin":33,"end":35},"obj":"Body_part"},{"id":"T16","span":{"begin":43,"end":47},"obj":"Body_part"},{"id":"T17","span":{"begin":93,"end":104},"obj":"Body_part"},{"id":"T18","span":{"begin":105,"end":115},"obj":"Body_part"},{"id":"T19","span":{"begin":155,"end":160},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma12520"},{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma62854"},{"id":"A18","pred":"fma_id","subj":"T18","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"s. In severe COVID-19 cases, the IL-33–ST2 axis might act to expand the number of pathogenic granulocyte–macrophage colony-stimulating factor-expressing T cells, dampen antiviral interferon responses, elicit hyperinflammation,"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":13,"end":21},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"s. In severe COVID-19 cases, the IL-33–ST2 axis might act to expand the number of pathogenic granulocyte–macrophage colony-stimulating factor-expressing T cells, dampen antiviral interferon responses, elicit hyperinflammation,"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T9","span":{"begin":39,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T10","span":{"begin":153,"end":160},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"s. In severe COVID-19 cases, the IL-33–ST2 axis might act to expand the number of pathogenic granulocyte–macrophage colony-stimulating factor-expressing T cells, dampen antiviral interferon responses, elicit hyperinflammation,"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":33,"end":35},"obj":"Chemical"},{"id":"T9","span":{"begin":169,"end":178},"obj":"Chemical"},{"id":"T10","span":{"begin":179,"end":189},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A8","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"}],"text":"s. In severe COVID-19 cases, the IL-33–ST2 axis might act to expand the number of pathogenic granulocyte–macrophage colony-stimulating factor-expressing T cells, dampen antiviral interferon responses, elicit hyperinflammation,"}

{"project":"LitCovid-PubTator","denotations":[{"id":"27","span":{"begin":33,"end":38},"obj":"Gene"},{"id":"28","span":{"begin":93,"end":141},"obj":"Gene"},{"id":"35","span":{"begin":39,"end":42},"obj":"Gene"},{"id":"39","span":{"begin":13,"end":21},"obj":"Disease"}],"attributes":[{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Gene:90865"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"Gene:1437"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"Gene:17082"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"s. In severe COVID-19 cases, the IL-33–ST2 axis might act to expand the number of pathogenic granulocyte–macrophage colony-stimulating factor-expressing T cells, dampen antiviral interferon responses, elicit hyperinflammation,"}